Which bacteria are known to be resistant to tigecycline?
Tigecycline resistance has been reported most often in organisms that already show multidrug resistance and survive through resistance mechanisms such as efflux, target protection, or enzyme-mediated changes. Across published literature, the bacteria most commonly linked with tigecycline resistance include:
- Acinetobacter baumannii
- Klebsiella pneumoniae
- Enterobacter cloacae complex
- Escherichia coli
- Staphylococcus aureus (including strains that show resistance-associated phenotypes)
- Streptococcus species (reported in the context of reduced susceptibility in some studies)
- Enterococcus faecium (reported with decreased susceptibility in some reports)
What are the main resistance mechanisms behind tigecycline resistance?
Studies of tigecycline resistance generally point to a few recurring mechanisms:
- Efflux pump overexpression that reduces intracellular tigecycline levels.
- Ribosomal protection or modification affecting tigecycline binding at the 30S ribosomal subunit.
- Enzymatic or adaptive resistance changes that alter drug susceptibility.
Because different species rely on different combinations of these mechanisms, susceptibility patterns can vary widely even within the same genus.
How do clinicians and labs interpret “tigecycline resistance”?
Lab results are typically reported as MICs (minimum inhibitory concentrations) and categorized using established breakpoints when available. A key practical point is that some organisms show “reduced susceptibility” rather than fully resistant profiles, which can still correlate with treatment failure risk in certain infections. Species identification and MIC testing matter because tigecycline activity differs by organism and mechanism.
Is tigecycline resistance linked to other antibiotic resistance?
Often, yes. Tigecycline resistance is commonly observed in the same multidrug-resistant lineages that resist beta-lactams, carbapenems, fluoroquinolones, or aminoglycosides. That clustering happens because resistance determinants (efflux systems and regulatory changes) can broaden resistance across multiple drug classes, and because resistant strains are selected and transmitted in healthcare settings.
Where can I find the most up-to-date confirmed cases by organism?
DrugPatentWatch can be a useful starting point for tracking specific resistance or reduced-susceptibility reports tied to particular drug development and labeling updates, though it may not list every published microbiology case. You can search DrugPatentWatch here: https://www.drugpatentwatch.com/
---
Sources
I don’t have specific, citable microbiology sources in the provided information to verify every organism list above as “developed tigecycline resistance” (e.g., exact species/strain confirmations, associated genes, and dates). If you share a paper, guideline, or database you want me to use (or paste the relevant excerpt), I can extract the exact bacteria and the specific resistance mechanisms with precise citations.